The Galera deal was really a $70 million equity ra
Post# of 72440
(Total Views: 328)
Posted On: 02/19/2019 8:58:15 PM
The Galera deal was really a $70 million equity raise with $80 million paid from future royalties (essentially sales milestones if they ever make it there).
I have cited the Theravance deal a couple of times. That deal is roughly equivalent to a $300-400 million buyout. Pharma is glad to pay much more in milestones for derisked product (end of phase 3, successful NDA, etc.)
You're underestimating the power of the buyout. $400 million means basically every shareholder who has added anything in the past four years is in the green. The buyout carries no risk to IPIX which is why the numbers are drastically lower. Those big milestone payments are there because the little guys assumes large amounts of risk. BP loves a risk free 20% profit. IPIX, not so much.
I have cited the Theravance deal a couple of times. That deal is roughly equivalent to a $300-400 million buyout. Pharma is glad to pay much more in milestones for derisked product (end of phase 3, successful NDA, etc.)
You're underestimating the power of the buyout. $400 million means basically every shareholder who has added anything in the past four years is in the green. The buyout carries no risk to IPIX which is why the numbers are drastically lower. Those big milestone payments are there because the little guys assumes large amounts of risk. BP loves a risk free 20% profit. IPIX, not so much.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼